SEDIA BIOSCIENCES CORPORATION
PORTLAND, OR · Founded 2009 · CIK 0001577322 · Medtech · Private
Diagnostic instruments that measure immune cell function and biomarkers for clinical and research use
sediabio.com →- Grants
- $3.6M
- 3 awards
- Sector median: 1
- Raised
- $285K
- 1 Form D · May 2013
- 160 months since last filing
- Contracts
- $1.3M
- 20 awards · Health and Human S, State
- #277 of 4531 in medtech
- Patents
- 8
- 2 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20102012201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Sedia Hiv-lag-avidity Eia | $31,240 | |
| Federal contract | Department of Health and Human Services · Sedia- Test Kits Bed Eia | $79,500 | |
| Federal contract | Department of Health and Human Services · Hiv Aag-avidity Eia Its | $149,100 | |
| Federal contract | Department of Health and Human Services · Hiv Test Kits | $53,350 | |
| Federal contract | Department of Health and Human Services · Hiv Lag Avidiity Test Kits | $201,550 | |
| Federal contract | Department of State · Igf::ot::igf | $8,450 | |
| Private capital raised | Form D · SEC | $284,998 | |
| Federal contract | Department of Health and Human Services · Igf::cl,ct::igf | $59,450 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf | $15,860 | |
| Federal contract | Department of State · Igf::cl::igf 7552.0/CDC-LAQ Assay | $35,200 | |
| Federal contract | Department of Health and Human Services · Sedia Hiv Eia Kits | $22,500 | |
| Federal contract | Department of Health and Human Services · Sedia HIV-1 Lag-avidity Eia | $45,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and Commercialization of an Innovative Rapid HIV-1 Incidence Assay | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and Commercialization of an Innovative Rapid HIV Incidence Assay | $1,791,483 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and Commercialization of an Innovative Rapid HIV-1 Incidence Assay | $791,483 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf | $68,015 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf | $92,565 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf | $22,650 | |
| Federal contract | Department of Health and Human Services · Asante Rapid Recency Kits And Reader | $112,060 | |
| Federal contract | Department of Health and Human Services · Sedia Biosciences Lab Supplies | $149,825 | |
| Federal contract | Department of Health and Human Services · Lab Supplies - Sedia Asante Rapid Recency Assay Kits | $119,155 | |
| Federal contract | Department of Health and Human Services · Lab Supplies And Equipment - Sedia Rapid Recency Kits | $82,263 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 274 | AutoGenomics, Inc. | $1.4M | $71M |
| 275 | YOU TUNE HEARING PROTECTION LLC | $1.4M | — |
| 276 | Turner Innovations L.C. | $1.3M | — |
| 277 | SEDIA BIOSCIENCES CORPORATION | $1.3M | $285K |
| 278 | Cellmic, LLC | $1.3M | — |
| 279 | Pharmaseq, Inc | $1.3M | — |
| 280 | LUMENASTRA | $1.3M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Roger GaleDirector · Executive Officer · Promoter
- Ronald MinkDirector · Executive Officer · Promoter
- Lynnor StevensonDirector
Patents
- Rapid Quantitative Assay To Assess Duration Of Infectionapplication
- Blood And Biological Sample Collection Device And Methodgranted
- Rapid Quantitative Assay To Assess Duration Of Infectionapplication
- Blood And Biological Sample Collection Device And Methodgranted
- Blood And Biological Sample Collection Device And Methodapplication
- A Rapid Quantitative Assay To Assess Duration Of Infectionapplication
- Blood And Biological Sample Collection Device And Methodapplication
- Blood Collection Device and Methodapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.